Aberrantly increased mRNA expression of betaglycan, an inhibin co-receptor in the ovarian tissues in women with polycystic ovary syndrome

Journal of Obstetrics and Gynaecology Research

Volumn 36, Issue 1, 2010, Pages 138-146

  Zhu, Rui ^a   Zhou, Xiping ^b   Chen, Youguo ^a   Qiu, Chenqiao ^a   Xu, Wenxin ^a   Shen, Zongji ^a  

^a THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^b SOOCHOW UNIVERSITY   (China)

Author keywords

Betaglycan; Inhibin B; Ovary; Polycystic ovary syndrome; Real time PCR

Indexed keywords

ACTIVIN A; ACTIVIN RECEPTOR; ACTIVIN RECEPTOR 1; ACTIVIN RECEPTOR 1A; ACTIVIN RECEPTOR 1B; ACTIVIN RECEPTOR 2; ACTIVIN RECEPTOR 2A; ACTIVIN RECEPTOR 2B; ESTRADIOL; FOLLITROPIN; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; INHIBIN; INHIBIN B; LUTEINIZING HORMONE; MESSENGER RNA; PROTEIN P120; TESTOSTERONE; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 3; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; ENDOCRINE FUNCTION; ESTRADIOL BLOOD LEVEL; FEMALE; FOLLICULAR PHASE; FOLLITROPIN BLOOD LEVEL; GENE EXPRESSION; HORMONE DETERMINATION; HUMAN; HUMAN TISSUE; LUTEINIZING HORMONE BLOOD LEVEL; MENSTRUAL CYCLE; OVARY; OVARY POLYCYSTIC DISEASE; REAL TIME POLYMERASE CHAIN REACTION; RNA ISOLATION; TESTOSTERONE BLOOD LEVEL;

ADULT; FEMALE; GENE EXPRESSION REGULATION; HUMANS; INHIBINS; OVARY; POLYCYSTIC OVARY SYNDROME; PROTEOGLYCANS; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; RNA, MESSENGER; YOUNG ADULT;

EID: 76349122190     PISSN: 13418076     EISSN: 14470756     Source Type: Journal    
DOI: 10.1111/j.1447-0756.2009.01103.x     Document Type: Article

References (42)

1. Vale W, Rivier C, Hsueh A et al. Chemical and biological characterization of the inhibin family of protein hormones. Recent Prog Horm Res 1988 44 : 1 34.
2. Bilezikjian LM, Blount AL, Leal AM et al. Autocrine/paracrine regulation of pituitary function by activin, inhibin and follistatin. Mol Cell Endocrinol 2004 225 : 29 36.
3. Veronica J, Roberts SB, Albert ER et al. Expression of inhibin/activin system messenger ribonucleic acids and proteins in ovarian follicles women with polycystic ovarian syndrome. J Clin Endocrinol Metab 1994 79 : 1434 1438.
4. Sidis Y, Fujiwara T, Leykin L et al. Characterization of inhibin/activin subunit, activin receptor, and follistatin messenger ribonucleic acid in human and mouse oocytes: Evidence for activin's paracrine signaling from granulosa cells to oocytes. Biol Reprod 1998 59 : 807 812.
5. Knight PG. Roles of inhibins, activins, and follistatin in the female reproductive system. Front Neuroendocrinol 1996 17 : 476 509.
6. Lewis KA, Gray PC, Blount AL et al. Betaglycan binds inhibin and can mediate functional antagonism of activin signaling. Nature 2000 404 : 411 414.
7. de Kretser DM, Hedger MP, Loveland KL et al. Inhibins, activins and follistatin in reproduction. Hum Reprod Update 2002 8 : 529 541.
8. Robertson DM, Burger HG, Fuller PJ. Inhibin/activin and ovarian cancer. Endocr Relat Cancer 2004 11 : 35 49.
9. Florio P, Luisi S, Ciarmela P et al. Inhibins and activins in pregnancy. Mol Cell Endocrinol 2004 225 : 93 100.
10. Chen F, Weinberg RA. Biochemical evidence for the autophosphorylation and transphosphorylation of transforming growth factor beta receptor kinases. Proc Natl Acad Sci USA 1995 92 : 1565 1569.
11. Chen RH, Moses HL, Maruoka EM et al. Phosphorylation-dependent interaction of the cytoplasmic domains of the type I and type II transforming growth factor-beta receptors. J Biol Chem 1995 270 : 12235 12241.
12. Pangas SA, Woodruff TK. Activin signal transduction pathways. Trends Endocrinol Metab 2000 11 : 309 314.
13. Lebrun JJ, Vale WW. Activin and inhibin have antagonistic effects on ligand-dependent heteromerization of the type I and type II activin receptors and human erythroid differentiation. Mol Cell Biol 1997 17 : 1682 1691.
14. Martens JW, de Winter JP, Timmerman MA et al. Inhibin interferes with activin signaling at the level of the activin receptor complex in Chinese hamster ovary cells. Endocrinology 1997 138 : 2928 2936.
15. Chapman SC, Bernard DJ, Jelen J et al. Properties of inhibin binding to betaglycan, InhBP/p120 and the activin type II receptors. Mol Cell Endocrinol 2002 196 : 79 93.
16. Gray PC, Bilezikjian LM, Vale W. Antagonism of activin by inhibin and inhibin receptors: A functional role for betaglycan. Mol Cell Endocrinol 2002 188 : 254 260.
17. Chong H, Pangas SA, Bernard DJ et al. Structure and expression of a membrane component of the inhibin receptor system. Endocrinology 2000 141 : 2600 2607.
18. Bernard DJ, Chapman SC, Woodruff TK. Inhibin binding protein (InhBP/p120), betaglycan, and the continuing search for the inhibin receptor. Mol Endocrinol 2002 16 : 207 212.
19. Roberts VJ, Barth S, el-Roeiy A et al. Expression of inhibin/activin subunits and follistatin messenger ribonucleic acids and proteins in ovarian follicles and the corpus luteum during the human menstrual cycle. J Clin Endocrinol Metab 1993 77 : 1402 1410.
20. Groome NP, Illingworth PJ, O'Brien M et al. Measurement of dimeric inhibin B throughout the human menstrual cycle. J Clin Endocrinol Metab 1996 81 : 1401 1405.
21. Magoffin DA, Jakimiuk AJ. Inhibin A, inhibin B and activin A concentrations in follicular fluid from women with polycystic ovary syndrome. Hum Reprod 1998 13 : 2693 2698.
22. Carmina E, Azziz R. Diagnosis, phenotype, and prevalence of polycystic ovary syndrome. Fertil Steril 2006 86 (Suppl 1 S7 S8. (Pubitemid 43913772)
23. The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004 81 : 19 25.
24. The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004 19 : 41 47.
25. Anderson RA, Groome NP, Baird DT. Inhibin A and inhibin B in women with polycystic ovarian syndrome during treatment with FSH to induce mono-ovulation. Clin Endocrinol 1998 48 : 577 584.
26. Lockwood GM, Muttukrishna S, Groome NP et al. Mid-follicular phase pulses of inhibin B are absent in polycystic ovarian syndrome and are initiated by successful laparoscopic ovarian diathermy: A possible mechanism regulating emergence of the dominant follicle. J Clin Endocrinol Metab 1998 83 : 1730 1735.
27. Shen ZJ, Chen XP, Chen YG. Inhibin B, activin A, and follistatin and the pathogenesis of polycystic ovary syndrome. Int J Gynaecol Obstet 2005 88 : 336 337.
28. Norman RJ, Milner CR, Groome NP et al. Circulating follistatin concentrations are higher and activin concentrations are lower in polycystic ovarian syndrome. Hum Reprod 2001 16 : 668 672.
29. Liu J, Kuulasmaa T, Kosma VM et al. Expression of betaglycan, an inhibin coreceptor, in normal human ovaries and ovarian sex cord-stromal tumors and its regulation in cultured human granulosa-luteal cells. J Clin Endocrinol Metab 2003 88 : 5002 5008.
30. Laven JS, Imani B, Eijkemans MJ, de Jong FH, Fauser BC. Absent biologically relevant associations between serum inhibin B concentrations and characteristics of polycystic ovary syndrome in normogonadotrophic anovulatory infertility. Hum Reprod 2001 16 : 1359 1364.
31. Welt CK, Taylor AE, Martin KA, Hall JE. Serum inhibin B in polycystic ovary syndrome: Regulation by insulin and luteinizing hormone. J Clin Endocrinol Metab 2002 87 : 5559 5565.
32. Eldar-Geva T, Spitz IM, Groome NP, Margalioth EJ, Homburg R. Follistatin and activin A serum concentrations in obese and non-obese patients with polycystic ovary syndrome. Hum Reprod 2001 16 : 2552 2556.
33. Pigny P, Cortet-Rudelli C, Decanter C et al. Serum levels of inhibins are differentially altered in patients with polycystic ovary syndrome: Effects of being overweight and relevance to hyperandrogenism. Fertil Steril 2000 73 : 972 977.
34. Cortet-Rudelli C, Pigny P, Decanter C et al. Obesity and serum luteinizing hormone level have an independent and opposite effect on the serum inhibin B level in patients with polycystic ovary syndrome. Fertil Steril 2002 77 : 281 287.
35. Tsigkou A, Luisi S, De Leo V et al. High serum concentration of total inhibin in polycystic ovary syndrome. Fertil Steril 2008 90 : 1859 1863.
36. Zhang Z, Lee VW, Carson RS, Burger HG. Selective control of rat granulosa cell inhibin production by FSH and LH in vitro. Mol Cell Endocrinol 1988 56 : 35 40.
37. Aloi JA, Dalkin AC, Schwartz NB et al. Ovarian inhibin subunit gene expression: Regulation by gonadotropins and estradiol. Endocrinology 1995 136 : 1227 1232.
38. Welt CK, Schneyer AL. Differential regulation of inhibin B and inhibin a by follicle-stimulating hormone and local growth factors in human granulosa cells from small antral follicles. J Clin Endocrinol Metab 2001 86 : 330 336.
39. Welt CK, Smith ZA, Pauler DK, Hall JE. Differential regulation of inhibin A and inhibin B by luteinizing hormone, follicle-stimulating hormone, and stage of follicle development. J Clin Endocrinol Metab 2001 86 : 2531 2537.
40. Erämaa M, Hildén K, Tuuri T, Ritvos O. Regulation of inhibin/activin subunit messenger ribonucleic acids (mRNAs) by activin A and expression of activin receptor mRNAs in cultured human granulosa-luteal cells. Endocrinology 1995 136 : 4382 4389.
41. Shimizu T, Jayawardana BC, Nishimoto H, Kaneko E, Tetsuka M, Miyamoto A. Involvement of the bone morphogenetic protein/receptor system during follicle development in the bovine ovary: Hormonal regulation of the expression of bone morphogenetic protein 7 (BMP-7) and its receptors (ActRII and ALK-2). Mol Cell Endocrinol 2006 249 : 78 83.
42. Chapman SC, Woodruff TK. Modulation of activin signal transduction by inhibin B and inhibin-binding protein (INhBP). Mol Endocrinol 2001 15 : 668 679.